He, Guo-Wei, Cheng-Qin Yang, Wolfgang F. Graier, and Jian-An Yang. Hyperkalemia alters EDHF-mediated hyperpolarization and relaxation in coronary arteries. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H760-H767, 1996.-Hyperkalemic solutions are widely used to preserve organs for transplantation and for cardiac surgery. The present study was designed to test the hypothesis that hyperkalemia may alter endothelial function through a non-nitric oxide (NO) pathway, since preliminary studies have shown that the NO pathway may not be affected. Porcine coronary artery rings were studied in organ chambers. After incubation with 20 or 50 mM K+ for 1 h, the indomethacinand NG-nitro-Larginine (L-NNA)-resistant relaxation induced by A23187 or bradykinin, which could be further inhibited by tetraethylammonium but not glibenclamide, was significantly reduced. Incubation with hyperkalemia also significantly increased the concentration eliciting 50% of the maximal response to A23187 and bradykinin.
A23187-induced hyperpolarization of the membrane potential was significantly reduced by hyperkalemic incubation. However, l-h incubation with hyperkalemia does not affect the endothelial Ca2+ concentration. We conclude that exposure to hyperkalemia reduces the indomethacinand L-NNA-resistant endothelium-dependent relaxation and endothelium-dependent hyperpolarization. This reduction in the relaxation and hyperpolarization is related to the endothelium-derived hyperpolarizing factor by affecting its effect on the smooth muscle cell, probably through partially depolarizing the membrane, and the Ca2+-activated K+ channels rather than by affecting its biosynthesis and/or release in the endothelial cell. Our study may suggest a new mechanism for coronary dysfunction after exposure to hyperkalemic cardioplegia and organ preservation solutions.
endothelium-derived relaxing factor; endothelium-derived hyperpolarizing factor; calcium ionophore; bradykinin; potassium channels; coronary artery ENDOTHELIUM-DEPENDENT relaxation is known to be the effect of a variety of different endothelium-derived relaxing factors (EDRFs). These are endotheliumderived nitric oxide (EDNO), prostacyclin (PGI& and endothelium-derived hyperpolarizing factor (EDHF). EDHF induces vascular smooth muscle relaxation via hyperpolarization of the smooth muscle cells (4, 7, 19, 24, 26) , which may involve K+ channels (5, 9, 15) . In contrast, EDNO relaxes blood vessels through the guanosine 3',5'-cyclic monophosphate pathway and does not hyperpolarize the vascular smooth muscle cells in some vessels or species (3, 7). All of these EDRFs are released in response to the increase of intracellular (cytosolic free) Ca2+ concentration in the endothelial cell (8).
A uniform conclusion regarding the effect of hyperkalemic solutions on the endothelial function has not been reached, although it is the focus of several recent studies (6, 13, 14, 20) . An important question is whether exposure to hyperkalemic solutions alters endothelial function. In perfused rat hearts, previous studies have suggested that infusion of hyperkalemic cardioplegic solution damages coronary endothelium (21). In contrast, we (13,14) and others (6) have demonstrated that exposure to hyperkalemic solutions for up to 4 h does not alter the noncyclooxygenase pathway-mediated endothelium-dependent relaxation in porcine coronary arteries (14) or neonatal rabbit aortas (13). However, the effect of hyperkalemia on noncyclooxygenase and non-EDNO-mediated endothelium-dependent (presumably EDHF-mediated) relaxation is unknown. If hyperkalemia alters this relaxation, it would have strong clinical implications because hyperkalemic solutions (containing 16-140 mM K+) are widely used for myocardial protection in cardiac surgery and for preservation of various organs for transplantation.
The present study was designed to examine the effect of hyperkalemia on indomethacin and NG-nitro-L-arginine (L-NNA)-resistant (noncyclooxygenase and non-EDNO mediated), i.e., EDHF-mediated, endothelium-dependent relaxation in the porcine coronary artery.
MATERIALS AND METHODS

Organ Bath Studies
Coronary arteries were obtained from porcine hearts that were harvested in a local abattoir. Immediately after the hog (either sex) was killed, the heart was rapidly removed, placed in a container filled with Krebs solution at 4"C, and transferred to the laboratory. Epicardial coronary arteries were dissected free of surrounding connective tissue, cut into 3-mm-long rings, and mounted on a pair of stainless steel wires in organ chambers (10) filled with Krebs solution at 37°C. The Krebs solution had the following composition (in mM): 144 Na+, 5.9 K+, 2.5 Ca2', 1.2 Mg2+, 128.7 Cl-, 25 HCO,, 1.2 SO;-, 1.2 H2P0,, and 11 glucose. The solution was aerated with a gas mixture of 95% O2-5% Co2 at 37°C. Four organ chamber arrangements were run concurrently. A previously described organ-chamber technique (10) was used to normalize vascular rings under a pressure simulating the conditions encountered at the artery at its normal transmural pressure, according to their own length-tension curves. The normalization procedure was performed with a computerized program (VESTAND by Y.-H. He, Princeton University, NJ).
The endothelium was intentionally preserved by cautiously dissecting and mounting the rings (10, 12). In some rings, the endothelium was mechanically removed to examine the endothelium dependence of the relaxation to A23187 or H760 HYPERKALEMIA ALTERS EFFECT OF EDHF H761 bradykinin (n = 4-7/group). In endothelium-denuded rings, nitroglycerin (-4.5 log M) was added at the end of the experiments to test whether those rings were still able to be relaxed with this endothelium-independent vasorelaxant (14).
Protocol
All rings were equilibrated for 30 min before and after normalization.
U-46619 (30 nM) was then added into the organ chamber to contract the rings. When the contraction reached a stable plateau (usually 10 min), cumulative concentration-response curves were established as follows. A23187.
Concentrations were -10 to -6.5 log M for A23187.
CONTROL.
The concentration-relaxation curves were established with the presence of the following combinations of inhibitors: 1) 7 uM indomethacin, a cyclooxygenase inhibitor, and 300 uM L-NNA, a nitric oxide (NO) biosynthesis and/or release inhibitor;
2) 7 uM indomethacin, 300 uM L-NNA, and 1 mM tetraethylammonium (TEA), a Ca2+-activated K+ channel (Kca channel) blocker; 3) 7 uM indomethacin, 300 uM L-NNA, and 3 uM glibenclamide (GBM), an ATP-sensitive K+ channel (K ATp) blocker; and 4) 7 uM indomethacin and 3 uM GBM.
HYPERKALEMIA
TREATMENT.
In Separate experiments, rings were exposed to hyperkalemic solutions containing 20 mM K+ in Krebs solution.
After exposure for 1 h, the chamber solutions were changed back to normal Krebs again, and the rings were frequently washed with Krebs to restore the baseline. Protocols l-3 (listed above) were repeated before the concentration-relaxation curves to A23 187 were established.
Other arteries were incubated with 50 mM K+ in Krebs solution. After incubation, protocoZ 1 was studied in those arteries.
Bradykinin. The concentrations for bradykinin were -11 to -6.5 log M. In control rings, protocoZs 1, 2, and 4 were studied. In the hyperkalemia-exposure experiments, the rings were incubated with 50 mM K' for 1 h. The chamber solution was changed back to normal Krebs again, and the rings were frequently washed by Krebs for 30 min to restore the baseline. Protocols 1,2, and 4 were studied.
Indomethacin, L-NNA, GBM, and TEA were added 30 min before the concentration-relaxation curves for A23 187 or bradykinin were started. Only one concentration-relaxation curve was obtained from each coronary ring. From a number of rings in each group of experiments, a mean concentrationrelaxation curve was constructed. During the experiments, the solutions in the organ chamber were continuously aerated with a mixture of 95% 02-5% Co2.
Electrophysiological
Studies (Membrane Potential Measurement) Porcine coronary rings were cut along the longitudinal axis and mounted, with the intimal side upward, on the bottom of a 2.5-ml organ bath. After 60 min of equilibrium, a glass microelectrode filled with 3 M KC1 (tip resistance 40-80 M(1) was inserted into a smooth muscle cell from the endothelial side (3, 5, 7 washed to restore the resting membrane potential.
The artery was then exposed to the hyperkalemic solution (Krebs solution with 20 mM K+, which replaced Na+) for 1 h. During incubation, the artery was continuously perfused at the rate of 3 ml/min and was oxygenated with a mixture of 95% 02-5% Co2 to exclude the effect of ischemia. After the incubation, the artery was repeatedly washed with normal Krebs solution for 30 min, and the concentrationresponse curve was established for A23187 (-10 to -6 log M) with the presence of 7 uM indomethacin and 300 uM L-NNA for 30 min. In some arteries, the endothelium was denuded by the method described above. The concentration-response curve to A23187 was also established in these arteries to examine the endothelium dependence of the A23 187-induced membrane hyperpolarization.
Measurement of EndotheZiaZ Cell Ca2+ Concentration
Single endothelial cell Ca2+ concentration was monitored with a microfluorometer (8). Endothelial cells were freshly isolated from porcine epicardial coronary arteries as previously described (8). Cells were loaded with 2 uM fura 2 acetoxymethyl ester for 30 min, washed, and equilibrated for further 30 min in Dulbecco's modified Eagle's medium (DMEM) at 37°C in the dark. Experiments were performed at 25°C with a constant superfusion of 1 ml/min. Because of the given uncertainties in calibration of the measured fluorescence signals to nanomolar free Ca2+ (B), all data are expressed as a ratio, F3&F380. Experimental protocol. Fura 2-loaded cells were placed for 60 min in 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid-buffered solution containing (in mM) 1.8 CaC12, 1 MgC12, 5 KCl, and 145 NaCl with pH adjusted at 7.4 (normal buffer solution) or in high-K+ solution containing (in mM) 1.8 CaC12, 1 MgC12, 50 KCl, and 100 NaCl with pH adjusted at 7.4. Before the experiments, cells were centrifuged and resuspended in normal buffer, and experiments were started -5 min after centrifugation.
Endothelial Ca2+ was increased with 5 uM bromo (Br)-A23187.
Data Analysis
The effective concentration of the relaxation agent that caused 50% of the maximal contraction (or relaxation) (EC& was determined from each concentration-relaxation curve by a logistic curve-fitting equation: E = MAPI(AP + K"), where E is the response, M is the maximal contraction (or relaxation), A is the concentration, K is the EC& concentration, and P is the slope parameter (2). 
Organ Bath Studies
Influence of inhibitors on resting force (tone). The change of the resting force by various inhibitors was minimal. In any group, indomethacin plus GBM did not affect the tone at all. However, indomethacin plus L-NNA slightly increased the tone. In the control rings, the change of the tone was 0.1 ? 0.1 g in A23187 group and 0.1 t 0.06 g in bradykinin group. In the rings treated with 20 mM K+, the change of the tone was 0.9 ? 0.3 in the A23187 group. In the rings treated with 50 mM K+, the change of the tone was 1.1 2 0.4 in the A23187 group and 0.5 t 0.2 g in the bradykinin group. Indomethacin, L-NNA, and TEA also slightly increased the tone in the control rings. The increase of the tone was 1.3 t 0.6 g, and it was 1.1 t 0.6 g after the treatment with 20 mM K+.
Comparison of precontraction. Precontraction by U-46619 was affected by the inhibitors. In A23187-related experiments, after treatment with indomethatin and L-NNA (n = 6), the developed force by U-46619 was 13.8 ? 2.9 g, whereas it was 3.9 t 1.1 g with indomethacin and GBM (n = 5) and 7.4 ? 0.8 g with indomethacin, L-NNA, and TEA (n = 7). Table 1 gives the details of these changes. In bradykinin experiments, the precontraction by U-46619 was 8.4 t 1.1 g in the rings treated with indomethacin, 10.0 t 0.4 g with indomethacin and L-NNA, 6.9 t 0.4 g with indomethacin, L-NNA, and GBM, and 7.7 t 1.7 g with indomethacin, L-NNA, and TEA.
AZ3187-induced relaxation. In the control rings, treatment with indomethacin (n = 5), indomethacin plus L-NNA (n = 6), indomethacin plus GBM (n = 5), or the combination of indomethacin, L-NNA, and GBM (n = 6) did not change the maximal relaxation (96.0 t 2.0% without treatment, n = 6, vs. 98.0 t 0.8% with indomethacin, 93.0 t 1.9% with indomethacin + L-NNA, 76.9 t 9.0% with indomethacin + GBM, and 70.2 ? Table 1 . Precontraction force induced by U-46619 14.5% with indomethacin, L-NNA, and GBM, P > 0.05, ANOVA). However, the relaxation was significantly reduced by treatment with indomethacin, L-NNA, and TEA(8.0 5 5.4%, Fig. 1A ).
Exposure to hyperkalemia (either 20 or 50 mM KS) significantly reduced the maximal relaxation in the rings treated with indomethacin and L-NNA. In the rings treated with 20 mM K+ (n = s>, the relaxation was reduced to 24.9 ? 14.1% (P = 0.0015, Scheffe's test, Fig. lB) , whereas in the rings treated with 50 mM KS (n = 7), the relaxation was 50.2 t 11.1% (P < 0.01; Fig 2) .
The ECFjo was significantly higher in the rings treated with either 20 or 50 mM K+ (Table 2 ).
In the endothelium-denuded rings, A23187 (n = 4) did not induce relaxation, and this confirms that the A23 187-induced relaxations observed in the present study were endothelium dependent ( Figs. 1 and 2) . Subsequently, these rings were relaxed by nitroglycerin (-4.5 log M) to nearly full range (>80%; data not shown).
Bradykinin-induced relaxation. Indomethacin plus L-NNA partially blocked the bradykinin-induced relaxation (82.9 t 6.0 vs. 97.8 2 0.59% in control, P < 0.05). However, addition of GBM (+ indomethacin and L-NNA) did not further reduce the relaxation (83.4 t 3.2%, P = 0.9). In contrast, TEA, in addition to indomethacin and L-NNA, significantly reduced the relaxation to 14.8 t 8.2% (n = 7, P < 0.05). Hyperkalemic treatment (with 50 mM K+) significantly reduced the indomethacinand L-NNA-resistant relaxation (to 39.2 IT 15.2%, P < 0.05, Fig. 3A) . Hyperkalemic treatment also significantly reduced the relaxation when indomethacin, L-NNA, and GBM were present (44.2 t 11.6 vs. 83.4 t 3.2%, P = 0.001, Fig. 3B ). The relaxation was abolished after exposure to hyperkalemia when indomethacin, L-NNA, and TEA were present (4.9 2 1.5%, n = 7, Fig. 3C ). Similar to the results in the A23 187 experiments, in the endothelium-denuded rings, bradykinin (n = 4) did not induce relaxation, and this confirms that the bradykinin-induced relaxations observed in the present study were endothelium dependent (Fig. 3) . Subsequently, these rings were relaxed by nitroglycerin (-4.5 log M) to nearly full range 080%; data not shown).
Membrane Potential Measurement
The resting membrane potential was -61.3 5 1.1 mV (n = 6). in presence of 7 uM indomethacin and 300 uM NG-nitro-L-arginine (n = 6); 0, Indo + GBM, in presence of 7 uM Indo and 3 uM glibenclamide (n = 5); A, Indo + L-NNA + GBM, in presence of 7 uM Indo, 300 uM L-NNA, and 3 uM GBM (n = 6); a, Indo + L-NNA + TEA, in presence of 7 uM Indo, 300 uM L-NNA, and 1 mM tetraethylammonium (n = 6); n , E-, endothelium denuded (n = 4). B: 0, K2O/Indo + GBM, in presence of 7 uM Indo and 3 uM GBM after incubation with 20 mM KS for 1 h (n = 6); 0, K2O/Indo + L-NNA, in presence of 7 uM Indo and 300 uM L-NNAafter incubation with 20 mM K' for 1 h (n = 6); A, K2O/Indo + L-NNA + TEA(n = 6), in presence of 7 uM Indo, 300 uM L-NNA, and 1 mM TEA after incubation with 20 mM K+ for 1 h; a, E-, endothelium denuded (n = 4).
A23187-induced hyperpolarization.
A23187 induced concentration-dependent hyperpolarization in the coronary artery at -8.5 to -6 log M. The maximal hyperpolarization was -75.7 t 2.8 mV (n = 6). After incubation with 20 mM K+ for 1 h and repeated wash for 30 min, the membrane potential still remained higher than that in the control (-58.0 2 0.7 mV, n = 6, P = O.O3).At the concentrations of -8 to -6 log M, A23187-induced hyperpolarization was significantly inhibited by the previous hyperkalemic incubation (Fig. 4) . The difference was most significant at -6 log M (-64.7 t 2.7 vs. -75.7 ? 2.8 mV, P = 0.002). l , Indo + L-NNA (n = 6); 0, K5O/Indo + L-NNA (K50, after incubation with 50 mM K'; n = 7); A, E-, endothelium denuded (n = 4).
In the endothelium-denuded arteries, A23 187 did not induce significant hyperpolarization, and this demonstrated that the hyperpolarization was endothelium dependent.
Measurement of Endothelial Cell Ca2+ Concentration
Br-A23 187 significantly increased the intracellular Ca2+ concentration of endothelial cells. However, pretreatment with 50 mM K+ for 1 h did not significantly change the Ca2' concentration in either basal or stimulated condition (Fig. 5) .
DISCUSSION
The present study has demonstrated, for the first time, that indomethacin-and L-NNA-resistant endothelium-dependent relaxation and the associated membrane hyperpolarization in the coronary artery are reduced by exposure to hyperkalemia. We have also demonstrated that this reduction of the relaxation is unlikely to be due to the reduction of the biosynthesis and/or release of EDHF. Rather, it is most likely to be related to alteration in the effect of EDHF on the coronary smooth muscle cells after depolarization. Because hyperkalemic solutions are widely used for organ preservation and for cardioplegia during open-heart surgery, this finding has strong clinical implications, and our study may reveal a new mechanism for coronary dysfunction.
Methodology
In the present study, the porcine coronary arteries were set up at the optimal point of their own lengthtension curve. This allows comparable studies among vascular rings. Although the influence of the wiremounting method on the membrane potential and the influence of this on the effect of EDHF are still unclear, this method is also used by others for EDHF studies (3, 19) In our experiments, hyperkalemia was washed out by frequently changing the bath solution to Krebs. Because the coronary rings were mounted on wires, both exterior and interior surfaces of the ring fully contacted the solution, the washout was adequate, and this is demonstrated by the fact that the resting force returned to the baseline after the washout procedure. In the electrophysiological studies, we chose to wash out the preparations for 30 min, because this is the usual reperfusion period after exposure to hyperkalemic solutions in the clinical setting.
Effect of Hyperkalemia on Nonindomethacin Non-L-NNA-Sensitive EndotheliumDependent Relaxation
Because the other two major components of the endothelium-dependent relaxation (cyclooxygenase and EDNO pathways) were blocked by indomethacin and lndo + LNNA -11 -10 -9 -8 -7
Bradykinin log M -9 -8 -7 -6 Bradvkinin loa M L-NNA, the residual relaxation is obviously through the noncyclooxygenase and non-EDNO mechanism (i.e., related to effect of EDHF). In the porcine coronary artery, EDHF plays a role in endothelium-dependent relaxation. This is reflected by the observation that, even in the control rings treated with indomethacin and L-NNA, the relaxation to either A23187 (97.6%) or bradykinin (82.9%) was still nearly full. In relaxation induced by A23187, this residual relaxation was only slightly blocked by the KATP channel blocker GBM (to 70.2%) but was almost abolished by the Kc,1 channel blocker TEA (to 8.0%). This was also seen in the relaxation induced by bradykinin in which TEA, but not GBM, abolished the residual relaxation (to 4.9%). After exposure to hyperkalemia for 1 h, the residual (indomethacin and L-NNA resistant) relaxation was significantly reduced, and this demonstrates that the noncyclooxygenaseand non-EDNO-mediated relaxation is affected by the exposure. In contrast, in our previous studies (13, 14) , we demonstrated that EDNOrelated relaxation is not altered by the exposure to hyperkalemia.
Our present study also provides evidence for this. When NO was not inhibited (without adding L-NNA), the relaxation was not significantly affected by hyperkalemic exposure (Fig. 1B) . Hyperkalemia therefore alters the noncyclooxygenase-and non-EDNO-mediated but not the EDNO-mediated endothelium-dependent relaxation.
Another question is whether the effect of hyperkalemia on EDHF-mediated relaxation is agonist dependent. In this study, two agonists (A23187 and bradykinin) were used to test endothelium-dependent relaxation. They are stimulants for both EDNO and EDHF through a mechanism that increases the intracellular Ca2+ concentration in the endothelial cell (8, 15). However, bradykinin increases the Ca2+ concentration through a receptor mechanism, whereas A23187 is a Ca2' ionophore through a nonreceptor mechanism. In the present study, the non-cyclooxygenase-and non-EDNO-mediated relaxation induced by both bradykinin and A23187 was reduced by the incubation with hyperkalemia. This suggests that the influence of hyperkalemia on the non-cyclooxygenase-and non-EDNOmediated relaxation is not agonist dependent.
In our study, incubation with inhibitors affected the subsequent contraction by U-46619, although the basal tone was little affected. Indomethacin and GBM did not have any effect on the basal tone. However, L-NNA significantly increased the tone. This demonstrates that EDNO plays a role in regulating the basal tone in the porcine coronary artery. On the other hand, both GBM and TEA reduced the U-46619-induced contraction, and this implies that both KATP and Kc, channels may play a role in the U-46619-induced contraction. This is partially in accordance with a previous study suggesting that U-46619 blocks K,, channels (23) .
It is possible that a higher precontraction would be more dificult to relax. In our experiments, with presence of TEA or GBM, A23187-induced relaxation was either significantly or slightly reduced, compared with that in the control. It is therefore unlikely that the reduction of such relaxation in the rings treated with either TEA or GBM is due to the difference in the precontraction because it was less in those rings (Table  1) . Furthermore, the observations of the influence of hyperkalemia on relaxation had a control group (without exposure to hyperkalemia but treated with the same inhibitors), and the comparison was made at the same level of precontraction.
Hyperkalemia and Cytosolic Free Cazt Concentration
There are two possibilities that may account for the reduction of the non+NNA-and non-indomethacinsensitive relaxation. First, the treatment of hyperkalemia may decrease the production of the substance from the endothelial cell that is responsible for noncyclooxygenaseand non-EDNO-mediated relaxation (i.e., EDHF). If this is true, the endothelial CaZ+ concentration must be decreased in response to exposure to hyperkalemia because the release of EDHF is the result of an increase in intracellular Ca2+ (8). To test this hypothesis, we measured the intracellular Ca2+ concentration in the endothelial cell after exposure to hyperkalemia. However, this possibility is ruled out by our experiments. One-hour incubation with hyperkalemia did not decrease the cytosolic free Ca2+ concentration, and this suggests that the production of the substance responsible to the non+NNA-and non-indomethacin-sensitive relaxation is unlikely to be affected. Therefore the cause for the reduction in non-L-NNAand nonindomethacin-sensitive relaxation is more likely to be related to the second possibility (i.e., affecting the effect of this substance, EDHF, on smooth muscle cell).
Mechanism of Reduction of Residual (Non-L-NNA and Nonindomethacin Sensitive) Relaxation K+ channels are usually subdivided according to their mode of activation (3, 22) . The involvement of the subtype of K+ channels is probably species and agonist dependent (7). K ATp channels have been suggested to be involved in the hyperpolarization of smooth muscle by EDHF (5,9,X>. In rabbit cerebral arteries, the effect of EDHF induced by acetylcholine (ACh) may be inhibited by the KATp channel blocker GBM (9). In the guinea pig coronary artery, ACh-induced hyperpolarization is inhibited by the Kc, channel blocker TEA but not by GBM (5). However, hyperpolarization induced by pinacidil is inhibited by GBM but not TEA (5). More recently, a study has suggested that the Kc,? channels are likely to be involved in hyperpolarization in the coronary artery (22).
Our experiments using TEA and GBM demonstrate that, in the porcine coronary artery, the EDHF-related relaxation mainly involves Kc, channels. This is demonstrated by results showing that TEA, but not GBM, could almost abolish the residual relaxation resistant to indomethacin and L-NNA. In fact, GBM only slightly reduced relaxation when this was induced by A23187 (Fig. 1) . In b ra y d k inin-induced relaxation, it was not affected by GBM at all (cf. Fig. 3, A-C) . These observations are in accordance with previous studies demonstrating the role of Kc,, channels in the hyperpolarization in the coronary artery (22).
The direct evidence that hyperkalemia affects EDHFrelated relaxation is provided by the results of direct measurement of the membrane potential in the present study. After exposure to hyperkalemia for 1 h, A23187-induced hyperpolarization was significantly reduced at all concentrations (-10 to -6 log M; Fig. 4) . From the observation in the present study that hyperkalemic exposure reduces the non-cyclooxygenase-and non-EDNO-mediated relaxation and the knowledge that K+ is a membrane-depolarizing agent, it is logical to hypothesize that hyperkalemia depolarizes the membrane and that membrane hyperpolarization, in response to EDHF, therefore becomes more difficult.
Although the washout procedure restored the resting force of the vessel, it could be still partially depolarized but not to the point at which the vessel shows active tone before activation with U-46619. This was shown by our electrophysiological studies. After repeated wash for 30 min, the membrane potential was -58.0 mV, compared with the resting potential of -61.3 mV (P = 0.03) before exposure to hyperkalemia. However, the partial depolarization may only partially account for the reduced hyperpolarization, since the A23187-stimulated hyperpolarization was reduced to a greater extent (-64.7 vs. -75.7 mV, Fig. 4) .
Our experiments strongly suggest that the reduced residual relaxation described above is coupling with reduced hyperpolarization (i.e., coupling with a reduced effect of EDHF). This may imply that exposure to hyperkalemia may directly affect the response of the smooth muscle to EDHF, possibly through inhibiting the Kc, channels, since the effect of hyperkalemia is similar to that of TEA (Figs. 1 and 3) .
As to the concentration of K+, the present study demonstrates that, at least at concentrations of 20 and 50 mM, the altered non-cyclooxygenaseand non-EDNO-mediated relaxation is not K+ dose dependent. Indeed, there was no difference in the magnitude of the reduction in the non-cyclooxygenase-and non-EDNOmediated relaxation between treatments with 20 and 50mMK+.
If both EDNO and EDHF are active in regulating the tone of the coronary circulation, then the present study has proposed a new mechanism for coronary dysfunction after exposure to hyperkalemia. When the EDHFmediated relaxation is reduced, the artery must have a higher tendency to contract, and this may lead to coronary spasm that could be critical in myocardial perfusion. During cardiac surgery, the heart is arrested by hyperkalemic cardioplegic solutions. This is fulfilled by perfusion of cardioplegic solutions through coronary circulation. Such exposure may reduce the vasorelaxant effect of EDHF, as demonstrated in the present study.
In addition, hyperkalemic solutions such as the University of Wisconsin solution (containing K+ as high as 125 mM) or the Euro-Collins solution (containing 115 mM Kt ) have been widely used to preserve organs (heart, lung, a n o d th ers) (1, (16) (17) (18) 25) . Therefore our findings also have implications in organ transplantations. Hyperkalemic organ preservation solutions may also reduce the vasorelaxant effect of EDHF during preservation.
The limitation of the present study is that, from our study, it is unknown whether the influence of hyperkalemia on the effect of EDHF is temporary. This needs to be addressed in future studies. However, at the least, this effect exists immediately after the exposure to hyperkalemia that is directly related to reperfusion. This period is critical for the recovery of the heart or other organs after exposure to hyperkalemia.
We conclude that exposure to hyperkalemia reduces the indomethacin-and L-NNA-resistant endotheliumdependent relaxation and membrane hyperpolariza- 
